SCHEMBL25539082

SCHEMBL25539082

CCCCOC(=O)c1cc2cc(I)ccc2s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 9/20 0.46
TSHR P16473 5/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
LMNA P02545 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
MAPK1 P28482 2/20 0.41
CYP2D6 P10635 1/20 0.41
NR1H2 P55055 1/20 0.41
RNASEL Q05823 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 1/20 0.40
PDE4D Q08499 1/20 0.40
RAB9A P51151 1/20 0.40
TP53 P04637 1/20 0.39
ALDH1A1 P00352 2/20 0.39
HSD17B10 Q99714 1/20 0.39
HTR1A P08908 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30599858 0.86 PTPN2 (0.49) TSHRTDP1L3MBTL1CYP1A2CYP2C19
SCHEMBL1882906 0.86 PTPN2 (0.49) TSHRTDP1L3MBTL1CYP1A2CYP2C19
SCHEMBL14793756 0.85 MEN1 (0.45) ESR1TSHRTDP1L3MBTL1LMNA
SCHEMBL25539085 0.84 LMNA (0.53) ESR1TSHRTDP1L3MBTL1LMNA
SCHEMBL14793908 0.82 TSHR (0.41) ESR1TSHRTDP1L3MBTL1LMNA
SCHEMBL17149289 0.82 TSHR (0.46) ESR1TSHRTDP1L3MBTL1LMNA
SCHEMBL15698895 0.81 CLK1 (0.43) ESR1TSHRTDP1L3MBTL1LMNA
SCHEMBL4477252 0.79 MAPT (0.52) LMNASMN1; SMN2ALDH1A1HTR1ADRD2
SCHEMBL15698879 0.78 PTPN2 (0.42) ESR1TSHRLMNAMAPK1CYP3A4
SCHEMBL5935775 0.77 RAB9A (0.56) ESR1TSHRTDP1L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159573-A1 SMALL MOLECULE STAT PROTEIN DEGRADERS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159573-A1 SMALL MOLECULE STAT PROTEIN DEGRADERS STAT1, STAT3, STAT5A ESR1 130/4885TSHR 405/4885TDP1 2337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.